Investor Brand Network - Pain Relief Tribune

Investor Brand Network

Featured Most recent

317 results total, viewing 1 - 20

420 with CNW — New Poll Finds Majority in Utah Support Recreational Marijuana Legalization

A recent poll conducted on behalf of a Utah medical marijuana advocacy group indicates that most Utah residents would support a ballot initiative to legalize recreational marijuana. The survey … more

InvestorBrandNetwork (IBN) (via Investor Brand Network) | 3/25/25

AINewsBreaks – Adageis Is Bringing AI to the Forefront of Value-Based Care

Adageis, a leading healthcare technology company, is at the forefront of an industry shift as providers increasingly prioritize specific, high-impact artificial intelligence (“AI”) applications … more

InvestorBrandNetwork (IBN) (via Investor Brand Network) | 3/25/25

CurrencyNewsBreaks – MoneyShow Event to Spotlight Insights for Navigating 2025 Market Dynamics

MoneyShow, a premier producer of financial conferences for affluent investors, active traders, and financial advisors, has announced the return of Outlook 2025: Big Market Trends, Bold Investment … more

InvestorBrandNetwork (IBN) (via Investor Brand Network) | 3/25/25

GreenEnergyBreaks — SolarBank Corp. (NASDAQ: SUUN) (Cboe CA: SUNN) (FSE: GY2) Closes $8.5 Million Direct Offering with Institutional Investor

Disseminated on behalf of SolarBank Corporation SolarBank (NASDAQ: SUUN) (Cboe CA: SUNN) (FSE: GY2) has closed a registered direct offering with a single institutional investor, securing … more

InvestorBrandNetwork (IBN) (via Investor Brand Network) | 3/25/25

BioMedNewsBreaks — CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Reports Phase 2 Results for Berubicin in Glioblastoma Trial

CNS Pharmaceuticals (NASDAQ: CNSP) announced results from its Phase 2 clinical trial evaluating Berubicin for recurrent or progressive Glioblastoma Multiforme (GBM). While the study did not meet its … more

InvestorBrandNetwork (IBN) (via Investor Brand Network) | 3/25/25

BioMedNewsBreaks — Annovis Bio Inc. (NYSE: ANVS) to Present Late-Stage Alzheimer’s and Parkinson’s Data at AD/PD 2025

Annovis Bio (NYSE: ANVS), a clinical-stage drug platform company focused on neurodegenerative diseases, will present key data from its Phase 3 Parkinson’s and Phase 2/3 Alzheimer’s studies at the … more

InvestorBrandNetwork (IBN) (via Investor Brand Network) | 3/25/25

TechMediaBreaks – SKYX Platforms Corp. (NASDAQ: SKYX) Reports 48% Revenue Growth in 2024, Eyes Profitability in Second Half of 2025

SKYX Platforms (NASDAQ: SKYX) reported a 48% year-over-year revenue increase, reaching $86.3 million in 2024, including a record $23.7 million in fourth-quarter sales. The company narrowed its net … more

InvestorBrandNetwork (IBN) (via Investor Brand Network) | 3/25/25

InvestorNewsBreaks – Clene Inc. (NASDAQ: CLNN) to Present at Jones Las Vegas Technology and Innovation Conference

Clene (NASDAQ: CLNN), a clinical-stage biopharmaceutical company advancing treatments for neurodegenerative diseases such as ALS and MS, will participate in the Jones Las Vegas Technology and … more

InvestorBrandNetwork (IBN) (via Investor Brand Network) | 3/25/25

InvestorNewsBreaks – Soligenix Inc. (NASDAQ: SNGX) Taps IBN to Lead Corporate Communications Strategy

Soligenix (NASDAQ: SNGX), a late-stage biopharmaceutical company targeting rare diseases, has selected IBN to manage its corporate communications and investor outreach. Soligenix is advancing … more

InvestorBrandNetwork (IBN) (via Investor Brand Network) | 3/25/25

InvestorNewsBreaks – Datavault AI Inc. (NASDAQ: DVLT) Partners with NYIAX to Launch Ultrasonic Advertising Platform

Datavault AI (NASDAQ: DVLT), a leader in AI-driven data monetization, has signed a strategic licensing agreement with NYIAX to integrate its patented ADIO® technology into NYIAX’s Nasdaq-powered … more

InvestorBrandNetwork (IBN) (via Investor Brand Network) | 3/25/25

InvestorNewsBreaks – Centri Capital Conference to Showcase the Future of Capital Markets

Centri Business Consulting, LLC, one of the industry’s fastest-growing and most respected accounting and advisory firms, is set to host its Centri Capital Conference. Slated to take place at Nasdaq … more

InvestorBrandNetwork (IBN) (via Investor Brand Network) | 3/25/25

420 with CNW — Maryland Senate Approves Bill Protecting Rights of Rescue Workers, Firefighters Using Medical Marijuana

The Maryland state Senate has approved a measure aimed at protecting rescue and fire workers from being penalized for using medical cannabis while off duty. The legislation, introduced by Senator … more

InvestorBrandNetwork (IBN) (via Investor Brand Network) | 3/24/25

Recap of PDAC 2025: A Landmark Event for the Global Mining Industry

The 2025 Prospectors & Developers Association of Canada (“PDAC”) Convention wrapped up in style this March, solidifying its position as one of the world’s premier events for the mining and … more

InvestorBrandNetwork (IBN) (via Investor Brand Network) | 3/24/25

TechMediaBreaks – Thumzup Media Corp. (NASDAQ: TZUP) Reports Insider Stock Purchases and Accelerated Buybacks

Thumzup (NASDAQ: TZUP), an emerging player in social media branding and programmatic marketing, reported that company insiders acquired approximately $60,381 in common stock during the March 2025 … more

InvestorBrandNetwork (IBN) (via Investor Brand Network) | 3/24/25

ETH Denver Recap: Trends Shaping AI, DePIN, and Web3

ETHDenver 2025 was a major event in the blockchain world, bringing together innovators, developers, and industry leaders to discuss the future of Web3, artificial intelligence (AI), and … more

InvestorBrandNetwork (IBN) (via Investor Brand Network) | 3/24/25

BioMedNewsBreaks — Clene Inc. (NASDAQ: CLNN) Plans 2025 NDA Submission Following Positive ALS Trial Data

Clene (NASDAQ: CLNN), a late clinical-stage biopharmaceutical company, reported a full-year 2024 net loss of $39.4 million, or $5.67 per share, compared to a loss of $49.5 million in 2023. Revenue … more

InvestorBrandNetwork (IBN) (via Investor Brand Network) | 3/24/25

AINewsBreaks – Datavault AI Inc. (NASDAQ: DVLT) Joins IBM Partner Plus Program to Scale AI Data Monetization

Datavault AI (NASDAQ: DVLT), a leader in AI-powered data valuation and monetization, announced its inclusion in IBM’s Partner Plus program, joining a global network of 500 partners. The company … more

InvestorBrandNetwork (IBN) (via Investor Brand Network) | 3/24/25

Senate Panel in Florida Starts Discussing Bill Restricting Hemp Products

A proposal introduced by Sen. Colleen Burton that would ban delta-8 THC hemp products is being discussed by legislators in Florida. The measure, SB 438, would also restrict levels of delta-9 THC … more

InvestorBrandNetwork (IBN) (via Investor Brand Network) | 3/24/25

Latest Data Shows US Retail Sales Slowed While e-Commerce Gained Ground

Recent data from the U.S. Census Bureau reveals that retail sales have slowed nationwide amid a surge in e-commerce. A preliminary analysis of the latest retail sales figures suggests that … more

InvestorBrandNetwork (IBN) (via Investor Brand Network) | 3/24/25

More People are Microdosing Psychedelics to Ease the Challenges of Parenting

There is a growing trend in which parents take tiny doses of psychedelics like LSD and psilocybin in order to cope with the challenges of parenting. Is microdosing psychedelics for these reasons a … more

InvestorBrandNetwork (IBN) (via Investor Brand Network) | 3/24/25

1 | 2 | 3 | 4 | 5 | 6 | 7 … 16 | Next »

Currently viewing stories posted within the past 2 years.
For all older stories, please use our advanced search.

Top stories

Expanding Coverage for FDA-Approved GLP-1s Is Critical for Patient Safety

(NewsUSA) - The newest generation of GLP-1 drugs has delivered life-changing benefits to patients managing diabetes, obesity, heart disease, and other chronic health conditions. And yet even though …

Spring Forward – Don’t Let Varicose Veins Hold You Back

(NewsUSA) - As the cold of winter fades, spring brings a fresh sense of renewal—and for many, it’s the first time in months they’ll be showing off their legs again. But for some, the thought of revealing their legs can come with hesitation. This may be especially true for those with varicose veins.Varicose veins are a common condition that affects more than 30 million Americans.1 These enlarged veins, visible just beneath the skin, are not just a cosmetic issue – they can signal underlying vein disease that causes blood to flow backward and pool in lower leg veins, causing pain and discomfort.Varicose Veins as More Than Just a Cosmetic IssueWhile cosmetic concerns and wanting to feel comfortable in your skin can be reason enough for treatment, varicose veins may also be a potential sign of a more urgent health condition that requires early diagnosis and treatment.“Varicose veins go beyond appearance—they can be a sign of underlying vein disease that can lead to swelling, skin discoloration, general discomfort in the legs, and in more advanced cases cause venous ulcers,” said Dr. John Laird, Chief Medical Officer for Peripheral Vascular Health at Medtronic. “If these symptoms are familiar, I would encourage you to reach out to a doctor who can do an evaluation and determine the best course of treatment to help you find relief from pain and other symptoms.”Know If You’re at Risk and Learn How to Step Up Your HealthVaricose veins and vein disease don’t discriminate — anyone, regardless of age, gender, or race, can be affected. However, certain factors may increase your risk. A family history of vein disease, smoking, or obesity can make vein problems more likely.2 Additionally, women who are pregnant, taking birth control, or going through menopause may experience a higher risk due to hormonal changes that can relax vein walls, making it easier for veins to swell.2"Varicose veins can worsen over time if left untreated,” explained Dr. Laird. “But the good news is there are innovative treatments and simple self-care strategies that can help manage symptoms. Adopting a few healthy habits can make a significant difference."Regular exercise, maintaining a healthy weight, elevating your legs when possible, and avoiding prolonged sitting or standing are all helpful steps.3 Dr. Laird also recommends wearing compression socks to support improved circulation and relieve discomfort. Medtronic just marked the milestone of shipping over one million VenaSeal closure system units worldwide.A Quick and Easy Option for Varicose Vein TreatmentWhile lifestyle changes can help manage varicose veins, they won’t cure them. For a more permanent solution, treatments like VenaSeal™ are gaining popularity. This medical adhesive is a quick and effective way to treat varicose veins with minimal recovery time— and may not require compression stockings following the procedure.5-6 Following the procedure, your doctor can help you know when you are able get back to doing what you love— from outdoor activities to spending time with family.4-7Heather Anderson, a mom, avid runner, and boot camp enthusiast, opted for the VenaSeal procedure to treat her tired and achy legs. “The treatment was smooth. I was awake the whole time, felt no pain, and was incredibly comfortable,” Heather shared of her experience. “When it was done, I got up and walked right out. I’d recommend it to anyone.”Minimally invasive treatments like VenaSeal are becoming the go-to choice for people dealing with varicose veins. “More patients are choosing minimally invasive options to treat varicose veins,” Dr. Laird said. “Medtronic recently celebrated a huge milestone — shipping over one million units of the VenaSeal system worldwide, showing just how popular and effective this treatment has become.”VenaSeal is a procedure where a small tube is inserted into the affected vein, and a specially formulated medical adhesive is used to seal the vein walls together. This reroutes blood to healthier veins, providing long-term relief from pain and discomfort. The best part? While each patient experience is unique, pain is generally considered mild, and most are back to their daily activities with minimal downtime.4-7Break Free from Leg Pain this SpringIf you’re dealing with varicose veins, it might be time to take action. Life shouldn’t be limited by pain caused by vein disease. Relieve your leg pain and talk to your doctor about whether VenaSeal could be the right option for you – it’s a quick and effective treatment that can help you get back to enjoying the beach, the lake, the pool, or wherever your warm weather adventures take you.For more details, including important safety information, on VenaSeal, visit: https://www.medtronic.com/breakfree.SourcesGloviczki P, Comerota AJ, Dalsing MC, et al. The care of patients with varicose veins and associated chronic venous diseases: Clinical practice guidelines of the Society for Vascular Surgery and the American Venous Forum. J Vasc Surg. 2011;53(5 Suppl):2S–48S. doi: 10.1016/j.jvs.2011.01.079.Mayo Clinic: Varicose Veinshttps://www.mayoclinic.org/diseases-conditions/varicose-veins/symptoms-causes/syc-20350643National Heart Lung and Blood Institute: Varicose Veins https://www.nhlbi.nih.gov/health/varicose-veinsMorrison N, Gibson K, McEnroe S, et al. Randomized trial comparing cyanoacrylate embolization and radiofrequency ablation for incompetent great saphenous veins (VeClose). J Vasc Surg. 2015;61(4):985–994. doi: 10.1016/j.jvs.2014.11.071.Proebstle T, Alm J, Dimitri S, et al. Three-year follow-up results of the prospective European multicenter cohort study on cyanoacrylate embolization for treatment of refluxing great saphenous veins. J Vasc Surg Venous Lymphat Disord. 2021;9(2):329–334. doi: 10.1016/j.jvsv.2020.05.019.Almeida JI, Javier JJ, Mackay EG, Bautista C, Cher DJ, Proebstle TM. Thirty-sixth-month follow-up of first-in-human use of cyanoacrylate adhesive for treatment of saphenous vein incompetence. J Vasc Surg Venous Lymphat Disord. 2017;5(5):658–666. doi: 10.1016/j.jvsv.2017.03.016.Morrison N, Gibson, Vasquez M, et al. VeClose trial 12-month outcomes of cyanoacrylate closure versus radiofrequency ablation for incompetent great saphenous veins. J Vasc Surg Venous Lymphat Disord. 2017;5(3):321–330. doi: 10.1016/j.jvsv.2016.12.005.

Medicare Now Covers Less Invasive Colorectal Cancer Tests

(NewsUSA) - Expanded Screening Coverage Can Reduce Needless Deaths Colorectal cancer deaths are declining, but shocking regional, racial and ethnic disparities remain. According to the American …

Cuidando #NuestrosCorazones juntos: Construyendo comunidades con corazones saludables

(NewsUSA) - Aunque las enfermedades del corazón se pueden prevenir en gran medida, aun así, siguen siendo la principal causa de muerte en los Estados Unidos. Las enfermedades cardíacas afectan a …

Taking Care of #Our Hearts Together: Building Heart-Healthy Communities

(NewsUSA) - Heart disease is largely preventable, yet it’s still the leading cause of death in the United States. It affects millions of people, and its impact is not shared equally among all …

From the web

‘I Am Going Through Hell’: Job Loss, Mental Health, and the Fate of Federal Workers

Since the Trump administration began firing federal workers, they say they feel overwhelmed, have obtained or considered seeking psychiatric care and medication, and are anxious about paying their …

As opposition to fluoride grows, rural America risks a new surge of tooth decay

Many rural counties are short on dentists, and if they lose water fluoridation, tooth decay could surge to levels that have not been seen in decades, experts warn.

The high cost of clean creeks: Who should pay for the mounting litter problem?

By Will Atwater On Saturday, March 15, volunteers gathered at sites like West Point on the Eno River, where cool temperatures and gray skies greeted them. Wearing neon-colored vests and armed …

With measles on the rise, what we can learn from past epidemics

As the U.S. health system grapples with new outbreaks and the risk of old diseases making a comeback, we're looking to the past to inform how people in marginalized communities can prepare themselves …

HRV Is The Health Metric You’re Not Tracking (But Should Be) via British Vogue

British Vogue article by Rosamund Dean and Morgan Fargo, “HRV Is The Health Metric You’re Not Tracking (But Should Be)” shares important advice from HRV expert Marco Altini, PhD Thanks for …